[1] |
黄洁夫. 中国人体器官分配与共享[M]//黄洁夫. 中国器官移植发展报告(2019). 北京: 清华大学出版社, 2020: 18-19.
|
[2] |
FELLMANN M, BALSSA L, CLÉMENT E, et al. Postoperative complications and long-term outcomes of transplantation with expended criteria donors transplants[J]. Prog Urol, 2020, 30(12): 655-662. DOI: 10.1016/j.purol.2020.04.019.
|
[3] |
TAYLOR MJ, BAICU SC. Current state of hypothermic machine perfusion preservation of organs: the clinical perspective[J]. Cryobiology, 2010, 60(3 Suppl): S20-S35. DOI: 10.1016/j.cryobiol.2009.10.006.
|
[4] |
KATHS JM, PAUL A, ROBINSON LA, et al. Ex vivo machine perfusion for renal graft preservation[J]. Transplant Rev (Orlando), 2018, 32(1): 1-9. DOI: 10.1016/j.trre.2017.04.002.
|
[5] |
BELZER FO, SOUTHARD JH. Principles of solid-organ preservation by cold storage[J]. Transplantation, 1988, 45(4): 673-676. DOI: 10.1097/00007890-198804000-00001.
|
[6] |
MATSUOKA L, SHAH T, ASWAD S, et al. Pulsatile perfusion reduces the incidence of delayed graft function in expanded criteria donor kidney transplantation[J]. Am J Transplant, 2006, 6(6): 1473-1478. DOI: 10.1111/j.1600-6143.2006.01323.x.
|
[7] |
HENRY SD, GUARRERA JV. Protective effects of hypothermic ex vivo perfusion on ischemia/reperfusion injury and transplant outcomes[J]. Transplant Rev (Orlando), 2012, 26(2): 163-175. DOI: 10.1016/j.trre.2011.09.001.
|
[8] |
BRAT A, DE VRIES KM, VAN HEURN EWE, et al. Hypothermic machine perfusion as a national standard preservation method for deceased donor kidneys[J]. Transplantation, 2021, DOI: 10.1097/TP.0000000000003845 [Epub ahead of print].
|
[9] |
TINGLE SJ, FIGUEIREDO RS, MOIR JA, et al. Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation[J]. Cochrane Database Syst Rev, 2019, 3(3): CD011671. DOI: 10.1002/14651858.CD011671.pub2.
|
[10] |
PENG P, DING Z, HE Y, et al. Hypothermic machine perfusion versus static cold storage in deceased donor kidney transplantation: a systematic review and Meta-analysis of randomized controlled trials[J]. Artif Organs, 2019, 43(5): 478-489. DOI: 10.1111/aor.13364.
|
[11] |
RUIZ-HERNÁNDEZ M, GÓMEZ-DOS SANTOS V, DÍAZ-PÉREZ D, et al. Experience with hypothermic machine perfusion in expanded criteria donors: functional outcomes[J]. Transplant Proc, 2019, 51(2): 303-306. DOI: 10.1016/j.transproceed.2018.09.020.
|
[12] |
DION MS, MCGREGOR TB, MCALISTER VC, et al. Hypothermic machine perfusion improves Doppler ultrasonography resistive indices and long-term allograft function after renal transplantation: a single-centre analysis[J]. BJU Int, 2015, 116(6): 932-937. DOI: 10.1111/bju.12960.
|
[13] |
RIJKSE E, IJZERMANS JN, MINNEE RC. Machine perfusion in abdominal organ transplantation: current use in the Netherlands[J]. World J Transplant, 2020, 10(1): 15-28. DOI: 10.5500/wjt.v10.i1.15.
|
[14] |
SMITH TB, NICHOLSON ML, HOSGOOD SA. Advances in hypothermic and normothermic perfusion in kidney transplantation[J]. Transplantology, 2021, 2(4): 460-477.
|
[15] |
BELLINI MI, TORTORICI F, AMABILE MI, et al. Assessing kidney graft viability and its cells metabolism during machine perfusion[J]. Int J Mol Sci, 2021, 22(3): 1121. DOI: 10.3390/ijms22031121.
|
[16] |
JOCHMANS I, MOERS C, SMITS JM, et al. The prognostic value of renal resistance during hypothermic machine perfusion of deceased donor kidneys[J]. Am J Transplant, 2011, 11(10): 2214-2220. DOI: 10.1111/j.1600-6143.2011.03685.x.
|
[17] |
YUSHKOV YY, STERN J, YING A, et al. Identifying risk factors in renal allografts before transplant: machine-measured renal resistance and posttransplant allograft survival[J]. Prog Transplant, 2012, 22(2): 175-182. DOI: 10.7182/pit2012968.
|
[18] |
PATEL SK, PANKEWYCZ OG, NADER ND, et al. Prognostic utility of hypothermic machine perfusion in deceased donor renal transplantation[J]. Transplant Proc, 2012, 44(7): 2207-2212. DOI: 10.1016/j.transproceed.2012.07.129.
|
[19] |
PATEL SK, PANKEWYCZ OG, WEBER-SHRIKANT E, et al. Effect of increased pressure during pulsatile pump perfusion of deceased donor kidneys in transplantation[J]. Transplant Proc, 2012, 44(7): 2202-2206. DOI: 10.1016/j.transproceed.2012.07.109.
|
[20] |
PARIKH CR, HALL IE, BHANGOO RS, et al. Associations of perfusate biomarkers and pump parameters with delayed graft function and deceased donor kidney allograft function[J]. Am J Transplant, 2016, 16(5): 1526-1539. DOI: 10.1111/ajt.13655.
|
[21] |
GUZZI F, KNIGHT SR, PLOEG RJ, et al. A systematic review to identify whether perfusate biomarkers produced during hypothermic machine perfusion can predict graft outcomes in kidney transplantation[J]. Transpl Int, 2020, 33(6): 590-602. DOI: 10.1111/tri.13593.
|
[22] |
FAUCHER Q, ALARCAN H, SAUVAGE F-L, et al. Perfusate metabolomics content and tubular transporters expression during kidney graft preservation by hypothermic machine perfusion[EB/OL]. [2021-12-15]. https://www.medrxiv.org/content/10.1101/2021.09.27.21264167v2.
|
[23] |
GOWERS SAN, HAMAOUI K, VALLANT N, et al. An improved rapid sampling microdialysis system for human and porcine organ monitoring in a hospital setting[J]. Anal Methods, 2018, 10(44): 5273-5281. DOI: 10.1039/c8ay01807c.
|
[24] |
KONKEL B, LAVIN C, WU TT, et al. Fully automated analysis of OCT imaging of human kidneys for prediction of post-transplant function[J]. Biomed Opt Express, 2019, 10(4): 1794-1821. DOI: 10.1364/BOE.10.001794.
|
[25] |
STEICHEN C, GIRAUD S, BON D, et al. Barriers and advances in kidney preservation[J]. Biomed Res Int, 2018: 9206257. DOI: 10.1155/2018/9206257.
|
[26] |
MEISTER FA, CZIGANY Z, RIETZLER K, et al. Decrease of renal resistance during hypothermic oxygenated machine perfusion is associated with early allograft function in extended criteria donation kidney transplantation[J]. Sci Rep, 2020, 10(1): 17726. DOI: 10.1038/s41598-020-74839-7.
|
[27] |
JOCHMANS I, BRAT A, DAVIES L, et al. Oxygenated versus standard cold perfusion preservation in kidney transplantation (COMPARE): a randomised, double-blind, paired, phase 3 trial[J]. Lancet, 2020, 396(10263): 1653-1662. DOI: 10.1016/S0140-6736(20)32411-9.
|
[28] |
ROUSSELOT M, DELPY E, DRIEU LA ROCHELLE C, et al. Arenicola marina extracellular hemoglobin: a new promising blood substitute[J]. Biotechnol J, 2006, 1(3): 333-345. DOI: 10.1002/biot.200500049.
|
[29] |
KASIL A, GIRAUD S, COUTURIER P, et al. Individual and combined impact of oxygen and oxygen transporter supplementation during kidney machine preservation in a porcine preclinical kidney transplantation model[J]. Int J Mol Sci, 2019, 20(8): 1992. DOI: 10.3390/ijms20081992.
|
[30] |
LE MEUR Y, BADET L, ESSIG M, et al. First-in-human use of a marine oxygen carrier (M101) for organ preservation: a safety and proof-of-principle study[J]. Am J Transplant, 2020, 20(6): 1729-1738. DOI: 10.1111/ajt.15798.
|
[31] |
HOUTZAGER JHE, HEMELRIJK SD, POST ICJH, et al. The use of the oxygenated AirdriveTM machine perfusion system in kidney graft preservation: a clinical pilot study[J]. Eur Surg Res, 2020, 61(6): 153-162. DOI: 10.1159/000513493.
|
[32] |
BISSOLATI M, GAZZETTA PG, CALDARA R, et al. Renal resistance trend during hypothermic machine perfusion is more predictive of postoperative outcome than biopsy score: preliminary experience in 35 consecutive kidney transplantations[J]. Artif Organs, 2018, 42(7): 714-722. DOI: 10.1111/aor.13117.
|
[33] |
BISSOLATI M, CERCHIONE R, TERULLA A, et al. Renal resistance trend during hypothermic machine perfusion correlates with preimplantation biopsy score in transplantation of kidneys from extended criteria donors[J]. Transplant Proc, 2021, 53(6): 1823-1830. DOI: 10.1016/j.transproceed.2021.03.036.
|
[34] |
DE BEULE J, JOCHMANS I. Kidney perfusion as an organ quality assessment tool-are we counting our chickens before they have hatched?[J]. J Clin Med, 2020, 9(3): 879. DOI: 10.3390/jcm9030879.
|
[35] |
DIRITO JR, HOSGOOD SA, TIETJEN GT, et al. The future of marginal kidney repair in the context of normothermic machine perfusion[J]. Am J Transplant, 2018, 18(10): 2400-2408. DOI: 10.1111/ajt.14963.
|
[36] |
RIJKSE E, BOUARI S, KIMENAI HJAN, et al. Additional normothermic machine perfusion versus hypothermic machine perfusion in suboptimal donor kidney transplantation: protocol of a randomized, controlled, open-label trial[J]. Int J Surg Protoc, 2021, 25(1): 227-237. DOI: 10.29337/ijsp.165.
|
[37] |
WEISSENBACHER A, HUANG H, SURIK T, et al. Urine recirculation prolongs normothermic kidney perfusion via more optimal metabolic homeostasis-a proteomics study[J]. Am J Transplant, 2021, 21(5): 1740-1753. DOI: 10.1111/ajt.16334.
|
[38] |
CHANDAK P, PHILLIPS BL, UWECHUE R, et al. Dissemination of a novel organ perfusion technique: ex vivo normothermic perfusion of deceased donor kidneys[J]. Artif Organs, 2019, 43(11): E308-E319. DOI: 10.1111/aor.13499.
|
[39] |
HAMEED AM, LU DB, PATRICK E, et al. Brief normothermic machine perfusion rejuvenates discarded human kidneys[J]. Transplant Direct, 2019, 5(11): e502. DOI: 10.1097/TXD.0000000000000944.
|
[40] |
WEISSENBACHER A, LO FARO L, BOUBRIAK O, et al. Twenty-four-hour normothermic perfusion of discarded human kidneys with urine recirculation[J]. Am J Transplant, 2019, 19(1): 178-192. DOI: 10.1111/ajt.14932.
|
[41] |
RIJKSE E, DE JONGE J, KIMENAI HJAN, et al. Safety and feasibility of 2 h of normothermic machine perfusion of donor kidneys in the Eurotransplant Senior Program[J]. BJS Open, 2021, 5(1): zraa024. DOI: 10.1093/bjsopen/zraa024.
|
[42] |
KABAGAMBE SK, PALMA IP, SMOLIN Y, et al. Combined ex vivo hypothermic and normothermic perfusion for assessment of high-risk deceased donor human kidneys for transplantation[J]. Transplantation, 2019, 103(2): 392-400. DOI: 10.1097/TP.0000000000002299.
|
[43] |
HOSGOOD SA, NICHOLSON ML. First in man renal transplantation after ex vivo normothermic perfusion[J]. Transplantation, 2011, 92(7): 735-738. DOI: 10.1097/TP.0b013e31822d4e04.
|
[44] |
HOSGOOD SA, BARLOW AD, HUNTER JP, et al. Ex vivo normothermic perfusion for quality assessment of marginal donor kidney transplants[J]. Br J Surg, 2015, 102(11): 1433-1440. DOI: 10.1002/bjs.9894.
|
[45] |
HE X, CHEN G, ZHU Z, et al. The first case of ischemia-free kidney transplantation in humans[J]. Front Med (Lausanne), 2019, 6: 276. DOI: 10.3389/fmed.2019.00276.
|
[46] |
FERDINAND JR, HOSGOOD SA, MOORE T, et al. Cytokine absorption during human kidney perfusion reduces delayed graft function-associated inflammatory gene signature[J]. Am J Transplant, 2021, 21(6): 2188-2199. DOI: 10.1111/ajt.16371.
|
[47] |
BRASILE L, HENRY N, ORLANDO G, et al. Potentiating renal regeneration using mesenchymal stem cells[J]. Transplantation, 2019, 103(2): 307-313. DOI: 10.1097/TP.0000000000002455.
|
[48] |
ABURAWI MM, FONTAN FM, KARIMIAN N, et al. Synthetic hemoglobin-based oxygen carriers are an acceptable alternative for packed red blood cells in normothermic kidney perfusion[J]. Am J Transplant, 2019, 19(10): 2814-2824. DOI: 10.1111/ajt.15375.
|
[49] |
MINOR T, VON HORN C, PAUL A. Role of erythrocytes in short-term rewarming kidney perfusion after cold storage[J]. Artif Organs, 2019, 43(6): 584-592. DOI: 10.1111/aor.13403.
|
[50] |
MINOR T, VON HORN C, GALLINAT A, et al. First-in-man controlled rewarming and normothermic perfusion with cell-free solution of a kidney prior to transplantation[J]. Am J Transplant, 2020, 20(4): 1192-1195. DOI: 10.1111/ajt.15647.
|
[51] |
DIRITO JR, HOSGOOD SA, RESCHKE M, et al. Lysis of cold-storage-induced microvascular obstructions for ex vivo revitalization of marginal human kidneys[J]. Am J Transplant, 2021, 21(1): 161-173. DOI: 10.1111/ajt.16148.
|
[52] |
TIETJEN GT, HOSGOOD SA, DIRITO J, et al. Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys[J]. Sci Transl Med, 2017, 9(418): eaam6764. DOI: 10.1126/scitranslmed.aam6764.
|
[53] |
ZHAO L, HU C, HAN F, et al. Combination of mesenchymal stromal cells and machine perfusion is a novel strategy for organ preservation in solid organ transplantation[J]. Cell Tissue Res, 2021, 384(1): 13-23. DOI: 10.1007/s00441-020-03406-3.
|
[54] |
THOMPSON ER, CONNELLY C, ALI S, et al. Cell therapy during machine perfusion[J]. Transpl Int, 2021, 34(1): 49-58. DOI: 10.1111/tri.13780.
|
[55] |
SHAPEY IM, MUIESAN P. Regional perfusion by extracorporeal membrane oxygenation of abdominal organs from donors after circulatory death: a systematic review[J]. Liver Transpl, 2013, 19(12): 1292-1303. DOI: 10.1002/lt.23771.
|
[56] |
DEL RÍO F, ANDRÉS A, PADILLA M, et al. Kidney transplantation from donors after uncontrolled circulatory death: the Spanish experience[J]. Kidney Int, 2019, 95(2): 420-428. DOI: 10.1016/j.kint.2018.09.014.
|
[57] |
ALVAREZ-RODRIGUEZ J, DEL BARRIO-YESA R, TORRENTE-SIERRA J, et al. Posttransplant long-term outcome of kidneys obtained from asystolic donors maintained under extracorporeal cardiopulmonary bypass[J]. Transplant Proc, 1995, 27(5): 2903-2904.
|
[58] |
COLL E, MIÑAMBRES E, SÁNCHEZ-FRUCTUOSO A, et al. Uncontrolled donation after circulatory death: a unique opportunity[J]. Transplantation, 2020, 104(8): 1542-1552. DOI: 10.1097/TP.0000000000003139.
|
[59] |
PADILLA M, COLL E, FERNÁNDEZ-PÉREZ C, et al. Improved short-term outcomes of kidney transplants in controlled donation after the circulatory determination of death with the use of normothermic regional perfusion[J]. Am J Transplant, 2021, 21(11): 3618-3628. DOI: 10.1111/ajt.16622.
|
[60] |
ARTILES MEDINA A, BURGOS REVILLA FJ, ÁLVAREZ NADAL M, et al. Comparison of in situ preservation techniques for kidneys from donors after circulatory death: a systematic review and Meta-analysis[J]. Transl Androl Urol, 2021, 10(8): 3286-3299. DOI: 10.21037/tau-21-236.
|
[61] |
SHAPEY IM, SUMMERS A, AUGUSTINE T, et al. Systematic review to assess the possibility of return of cerebral and cardiac activity after normothermic regional perfusion for donors after circulatory death[J]. Br J Surg, 2019, 106(3): 174-180. DOI: 10.1002/bjs.11046.
|
[62] |
HESSHEIMER AJ, BILLAULT C, BARROU B, et al. Hypothermic or normothermic abdominal regional perfusion in high-risk donors with extended warm ischemia times: impact on outcomes?[J]. Transpl Int, 2015, 28(6): 700-707. DOI: 10.1111/tri.12344.
|
[63] |
BUTLER AJ, RANDLE LV, WATSON CJ. Normothermic regional perfusion for donation after circulatory death without prior heparinization[J]. Transplantation, 2014, 97(12): 1272-1278. DOI: 10.1097/TP.0000000000000082.
|
[64] |
ROJAS-PEÑA A, SALL LE, GRAVEL MT, et al. Donation after circulatory determination of death: the University of Michigan experience with extracorporeal support[J]. Transplantation, 2014, 98(3): 328-334. DOI: 10.1097/TP.0000000000000070.
|
[65] |
MIÑAMBRES E, SUBERVIOLA B, DOMINGUEZ-GIL B, et al. Improving the outcomes of organs obtained from controlled donation after circulatory death donors using abdominal normothermic regional perfusion[J]. Am J Transplant, 2017, 17(8): 2165-2172. DOI: 10.1111/ajt.14214.
|
[66] |
HOSGOOD SA, BROWN RJ, NICHOLSON ML. Advances in kidney preservation techniques and their application in clinical practice[J]. Transplantation, 2021, 105(11): e202-e214. DOI: 10.1097/TP.0000000000003679.
|
[67] |
REZNIK ON, SKVORTSOV AE, REZNIK AO, et al. Uncontrolled donors with controlled reperfusion after sixty minutes of asystole: a novel reliable resource for kidney transplantation[J]. PLoS One, 2013, 8(5): e64209. DOI: 10.1371/journal.pone.0064209.
|
[68] |
MOLINA M, GUERRERO-RAMOS F, FERNÁNDEZ-RUIZ M, et al. Kidney transplant from uncontrolled donation after circulatory death donors maintained by nECMO has long-term outcomes comparable to standard criteria donation after brain death[J]. Am J Transplant, 2019, 19(2): 434-447. DOI: 10.1111/ajt.14991.
|